Showing 1 - 5 results of 5 for search 'Bruno Sangro', query time: 0.03s Refine Results
  1. 1
    Exposure‐response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)

    Exposure‐response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040) by Bruno Sangro, Thomas Yau, Anthony B. El‐Khoueiry, Masatoshi Kudo, Yun Shen, Marina Tschaika, Amit Roy, Yan Feng, Ling Gao, Urvi Aras

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood

    Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood by Alejandro Rodríguez‐Pena, Estibaliz Armendariz, Alvaro Oyarbide, Xabier Morales, Sergio Ortiz‐Espinosa, Borja Ruiz‐Fernández de Córdoba, Denis Cochonneau, Iñaki Cornago, Dominique Heymann, Josepmaría Argemi, Delia D'Avola, Bruno Sangro, Fernando Lecanda, Ruben Pio, Iván Cortés‐Domínguez, Carlos Ortiz‐de‐Solórzano

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma

    Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma by Can G. Leineweber, Can G. Leineweber, Can G. Leineweber, Miriam Rabehl, Miriam Rabehl, Anne Pietzner, Anne Pietzner, Nadine Rohwer, Nadine Rohwer, Nadine Rohwer, Michael Rothe, Maciej Pech, Bruno Sangro, Rohini Sharma, Chris Verslype, Bristi Basu, Christian Sengel, Jens Ricke, Nils Helge Schebb, Karsten-H. Weylandt, Karsten-H. Weylandt, Julia Benckert

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma

    Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma by Can G. Leineweber, Can G. Leineweber, Can G. Leineweber, Miriam Rabehl, Miriam Rabehl, Anne Pietzner, Anne Pietzner, Nadine Rohwer, Nadine Rohwer, Nadine Rohwer, Michael Rothe, Maciej Pech, Bruno Sangro, Rohini Sharma, Chris Verslype, Bristi Basu, Christian Sengel, Jens Ricke, Nils Helge Schebb, Karsten-H. Weylandt, Karsten-H. Weylandt, Julia Benckert

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Prognostic role of radiomics‐based body composition analysis for the 1‐year survival for hepatocellular carcinoma patients

    Prognostic role of radiomics‐based body composition analysis for the 1‐year survival for hepatocellular carcinoma patients by Sylvia Saalfeld, Robert Kreher, Georg Hille, Uli Niemann, Mattes Hinnerichs, Osman Öcal, Kerstin Schütte, Christoph J. Zech, Christian Loewe, Otto vanDelden, Vincent Vandecaveye, Chris Verslype, Bernhard Gebauer, Christian Sengel, Irene Bargellini, Roberto Iezzi, Thomas Berg, Heinz J. Klümpen, Julia Benckert, Antonio Gasbarrini, Holger Amthauer, Bruno Sangro, Peter Malfertheiner, Bernhard Preim, Jens Ricke, Max Seidensticker, Maciej Pech, Alexey Surov

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: